Detalles de la búsqueda
1.
Long-term outcome and prognostic value of Ki67 after perioperative endocrine therapy in postmenopausal women with hormone-sensitive early breast cancer (POETIC): an open-label, multicentre, parallel-group, randomised, phase 3 trial.
Lancet Oncol
; 21(11): 1443-1454, 2020 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-33152284
2.
6 versus 12 months of adjuvant trastuzumab for HER2-positive early breast cancer (PERSEPHONE): 4-year disease-free survival results of a randomised phase 3 non-inferiority trial.
Lancet
; 393(10191): 2599-2612, 2019 06 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-31178152
3.
Partial-breast radiotherapy after breast conservation surgery for patients with early breast cancer (UK IMPORT LOW trial): 5-year results from a multicentre, randomised, controlled, phase 3, non-inferiority trial.
Lancet
; 390(10099): 1048-1060, 2017 Sep 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-28779963
4.
The Importance of Quality Patient Advocacy to Biobanks: A Lay Perspective from Independent Cancer Patients Voice (ICPV), Based in the United Kingdom.
Adv Exp Med Biol
; 864: 171-83, 2015.
Artículo
en Inglés
| MEDLINE | ID: mdl-26420622
5.
Targeted radiotherapy for early breast cancer - Authors' reply.
Lancet
; 391(10115): 27-28, 2018 01 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-29323651
6.
Six versus 12 months' adjuvant trastuzumab in patients with HER2-positive early breast cancer: the PERSEPHONE non-inferiority RCT.
Health Technol Assess
; 24(40): 1-190, 2020 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-32880572
7.
Randomized Phase II Study Evaluating Palbociclib in Addition to Letrozole as Neoadjuvant Therapy in Estrogen Receptor-Positive Early Breast Cancer: PALLET Trial.
J Clin Oncol
; 37(3): 178-189, 2019 01 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-30523750
8.
Patient advocate involvement in the design and conduct of breast cancer clinical trials requiring the collection of multiple biopsies.
Res Involv Engagem
; 4: 22, 2018.
Artículo
en Inglés
| MEDLINE | ID: mdl-30026963
9.
Addressing overtreatment of screen detected DCIS; the LORIS trial.
Eur J Cancer
; 51(16): 2296-303, 2015 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-26296293
10.
Chemotherapy and targeted therapy for women with human epidermal growth factor receptor 2-negative (or unknown) advanced breast cancer: American Society of Clinical Oncology Clinical Practice Guideline.
J Clin Oncol
; 32(29): 3307-29, 2014 Oct 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-25185096
11.
Endocrine therapy, new biologicals, and new study designs for presurgical studies in breast cancer.
J Natl Cancer Inst Monogr
; 2011(43): 120-3, 2011.
Artículo
en Inglés
| MEDLINE | ID: mdl-22043057
12.
In Regard to Vaidya et al.
Int J Radiat Oncol Biol Phys
; 92(5): 957-958, 2015 Aug 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-26194666
13.
Independent UK Panel on Breast Cancer Screening replies to Michael Baum.
BMJ
; 346: f873, 2013 Feb 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-23407732
Resultados
1 -
13
de 13
1
Próxima >
>>